Health Economics›T-cell acute lymphoblastic leukemia›Pre-phase

Pre-phase

T-cell acute lymphoblastic leukemia · 1 regimen

Cost estimates only — modelled on a typical patient (BSA 1.7 m², 70 kg, CrCl 90 mL/min) using the cheapest available formulary presentation. Excludes vial wastage, facility fees, supportive care, and infusion consumables. Not for billing, formulary decisions, or clinical use.

Filters

Y-axis

Cost vs Efficacy · 1 point

Fully pricedPartial pricing

Regimen	Biomarker	Cost/cycle ↓	Cycle	PFS ↕	OS ↕	Est. cycles	Course cost ↕	Evidence
Prednisone monotherapy Variant #11	—	R 22	7d	~2.2 mo	~14.1 mo	~10	~R 215 PFS proxy · indirect	8

1 of 1 regimen shown